Bicalutamide Market Report

Global Bicalutamide Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：235
  • REPORT CODE：GMM859170
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Bicalutamide market report explains the definition, types, applications, major countries, and major players of the Bicalutamide market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Zhejiang Haizheng Pharmaceutical

    • Shanghai Fudan Fuhua Pharmaceutical

    • Apotex Corporation

    • AstraZeneca

    • Sivem Pharmaceuticals

    • CORDEN PHARMA GMBH

    • Sorres Pharma

    • Zeneca GmbH

    • Accel Pharma

    • Fresenius Kabi

    • Actavis Pharma

    • ANI Pharmaceuticals

    • Shanghai Zhaohui Pharmaceutical

    • Shanxi Zhendong Pharmaceutical

    By Type:

    • Tablets

    • Capsule

    By End-User:

    • Single Drug For Prostate Cancer

    • Combined Chemotherapy For Prostate Cancer

    • Combined Radiation Therapy Or Castration For Prostate Cancer

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Bicalutamide Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Bicalutamide Outlook to 2028- Original Forecasts

    • 2.2 Bicalutamide Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Bicalutamide Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Bicalutamide Market- Recent Developments

    • 6.1 Bicalutamide Market News and Developments

    • 6.2 Bicalutamide Market Deals Landscape

    7 Bicalutamide Raw Materials and Cost Structure Analysis

    • 7.1 Bicalutamide Key Raw Materials

    • 7.2 Bicalutamide Price Trend of Key Raw Materials

    • 7.3 Bicalutamide Key Suppliers of Raw Materials

    • 7.4 Bicalutamide Market Concentration Rate of Raw Materials

    • 7.5 Bicalutamide Cost Structure Analysis

      • 7.5.1 Bicalutamide Raw Materials Analysis

      • 7.5.2 Bicalutamide Labor Cost Analysis

      • 7.5.3 Bicalutamide Manufacturing Expenses Analysis

    8 Global Bicalutamide Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Bicalutamide Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Bicalutamide Export by Region (Top 10 Countries) (2017-2028)

    9 Global Bicalutamide Market Outlook by Types and Applications to 2022

    • 9.1 Global Bicalutamide Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)

    • 9.2 Global Bicalutamide Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Single Drug For Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Combined Chemotherapy For Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Combined Radiation Therapy Or Castration For Prostate Cancer Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Bicalutamide Market Analysis and Outlook till 2022

    • 10.1 Global Bicalutamide Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Bicalutamide Consumption (2017-2022)

      • 10.2.2 Canada Bicalutamide Consumption (2017-2022)

      • 10.2.3 Mexico Bicalutamide Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Bicalutamide Consumption (2017-2022)

      • 10.3.2 UK Bicalutamide Consumption (2017-2022)

      • 10.3.3 Spain Bicalutamide Consumption (2017-2022)

      • 10.3.4 Belgium Bicalutamide Consumption (2017-2022)

      • 10.3.5 France Bicalutamide Consumption (2017-2022)

      • 10.3.6 Italy Bicalutamide Consumption (2017-2022)

      • 10.3.7 Denmark Bicalutamide Consumption (2017-2022)

      • 10.3.8 Finland Bicalutamide Consumption (2017-2022)

      • 10.3.9 Norway Bicalutamide Consumption (2017-2022)

      • 10.3.10 Sweden Bicalutamide Consumption (2017-2022)

      • 10.3.11 Poland Bicalutamide Consumption (2017-2022)

      • 10.3.12 Russia Bicalutamide Consumption (2017-2022)

      • 10.3.13 Turkey Bicalutamide Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Bicalutamide Consumption (2017-2022)

      • 10.4.2 Japan Bicalutamide Consumption (2017-2022)

      • 10.4.3 India Bicalutamide Consumption (2017-2022)

      • 10.4.4 South Korea Bicalutamide Consumption (2017-2022)

      • 10.4.5 Pakistan Bicalutamide Consumption (2017-2022)

      • 10.4.6 Bangladesh Bicalutamide Consumption (2017-2022)

      • 10.4.7 Indonesia Bicalutamide Consumption (2017-2022)

      • 10.4.8 Thailand Bicalutamide Consumption (2017-2022)

      • 10.4.9 Singapore Bicalutamide Consumption (2017-2022)

      • 10.4.10 Malaysia Bicalutamide Consumption (2017-2022)

      • 10.4.11 Philippines Bicalutamide Consumption (2017-2022)

      • 10.4.12 Vietnam Bicalutamide Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Bicalutamide Consumption (2017-2022)

      • 10.5.2 Colombia Bicalutamide Consumption (2017-2022)

      • 10.5.3 Chile Bicalutamide Consumption (2017-2022)

      • 10.5.4 Argentina Bicalutamide Consumption (2017-2022)

      • 10.5.5 Venezuela Bicalutamide Consumption (2017-2022)

      • 10.5.6 Peru Bicalutamide Consumption (2017-2022)

      • 10.5.7 Puerto Rico Bicalutamide Consumption (2017-2022)

      • 10.5.8 Ecuador Bicalutamide Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Bicalutamide Consumption (2017-2022)

      • 10.6.2 Kuwait Bicalutamide Consumption (2017-2022)

      • 10.6.3 Oman Bicalutamide Consumption (2017-2022)

      • 10.6.4 Qatar Bicalutamide Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Bicalutamide Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Bicalutamide Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Bicalutamide Consumption (2017-2022)

      • 10.7.2 South Africa Bicalutamide Consumption (2017-2022)

      • 10.7.3 Egypt Bicalutamide Consumption (2017-2022)

      • 10.7.4 Algeria Bicalutamide Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Bicalutamide Consumption (2017-2022)

      • 10.8.2 New Zealand Bicalutamide Consumption (2017-2022)

    11 Global Bicalutamide Competitive Analysis

    • 11.1 Zhejiang Haizheng Pharmaceutical

      • 11.1.1 Zhejiang Haizheng Pharmaceutical Company Details

      • 11.1.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Main Business and Markets Served

      • 11.1.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Shanghai Fudan Fuhua Pharmaceutical

      • 11.2.1 Shanghai Fudan Fuhua Pharmaceutical Company Details

      • 11.2.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Main Business and Markets Served

      • 11.2.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Apotex Corporation

      • 11.3.1 Apotex Corporation Company Details

      • 11.3.2 Apotex Corporation Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Apotex Corporation Bicalutamide Main Business and Markets Served

      • 11.3.4 Apotex Corporation Bicalutamide Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 AstraZeneca

      • 11.4.1 AstraZeneca Company Details

      • 11.4.2 AstraZeneca Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 AstraZeneca Bicalutamide Main Business and Markets Served

      • 11.4.4 AstraZeneca Bicalutamide Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sivem Pharmaceuticals

      • 11.5.1 Sivem Pharmaceuticals Company Details

      • 11.5.2 Sivem Pharmaceuticals Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sivem Pharmaceuticals Bicalutamide Main Business and Markets Served

      • 11.5.4 Sivem Pharmaceuticals Bicalutamide Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 CORDEN PHARMA GMBH

      • 11.6.1 CORDEN PHARMA GMBH Company Details

      • 11.6.2 CORDEN PHARMA GMBH Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 CORDEN PHARMA GMBH Bicalutamide Main Business and Markets Served

      • 11.6.4 CORDEN PHARMA GMBH Bicalutamide Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sorres Pharma

      • 11.7.1 Sorres Pharma Company Details

      • 11.7.2 Sorres Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sorres Pharma Bicalutamide Main Business and Markets Served

      • 11.7.4 Sorres Pharma Bicalutamide Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Zeneca GmbH

      • 11.8.1 Zeneca GmbH Company Details

      • 11.8.2 Zeneca GmbH Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Zeneca GmbH Bicalutamide Main Business and Markets Served

      • 11.8.4 Zeneca GmbH Bicalutamide Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Accel Pharma

      • 11.9.1 Accel Pharma Company Details

      • 11.9.2 Accel Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Accel Pharma Bicalutamide Main Business and Markets Served

      • 11.9.4 Accel Pharma Bicalutamide Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Fresenius Kabi

      • 11.10.1 Fresenius Kabi Company Details

      • 11.10.2 Fresenius Kabi Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Fresenius Kabi Bicalutamide Main Business and Markets Served

      • 11.10.4 Fresenius Kabi Bicalutamide Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Actavis Pharma

      • 11.11.1 Actavis Pharma Company Details

      • 11.11.2 Actavis Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Actavis Pharma Bicalutamide Main Business and Markets Served

      • 11.11.4 Actavis Pharma Bicalutamide Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 ANI Pharmaceuticals

      • 11.12.1 ANI Pharmaceuticals Company Details

      • 11.12.2 ANI Pharmaceuticals Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 ANI Pharmaceuticals Bicalutamide Main Business and Markets Served

      • 11.12.4 ANI Pharmaceuticals Bicalutamide Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Shanghai Zhaohui Pharmaceutical

      • 11.13.1 Shanghai Zhaohui Pharmaceutical Company Details

      • 11.13.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Main Business and Markets Served

      • 11.13.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Shanxi Zhendong Pharmaceutical

      • 11.14.1 Shanxi Zhendong Pharmaceutical Company Details

      • 11.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Main Business and Markets Served

      • 11.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Bicalutamide Market Outlook by Types and Applications to 2028

    • 12.1 Global Bicalutamide Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Bicalutamide Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Single Drug For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Combined Chemotherapy For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Combined Radiation Therapy Or Castration For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Bicalutamide Market Analysis and Outlook to 2028

    • 13.1 Global Bicalutamide Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Bicalutamide Consumption Forecast (2022-2028)

      • 13.2.2 Canada Bicalutamide Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Bicalutamide Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.2 UK Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.3 Spain Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.5 France Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.6 Italy Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.8 Finland Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.9 Norway Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.11 Poland Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.12 Russia Bicalutamide Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Bicalutamide Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.2 Japan Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.3 India Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Bicalutamide Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Bicalutamide Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.3 Chile Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.6 Peru Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Bicalutamide Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Bicalutamide Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Bicalutamide Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Bicalutamide Consumption Forecast (2022-2028)

      • 13.6.3 Oman Bicalutamide Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Bicalutamide Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Bicalutamide Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Bicalutamide Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Bicalutamide Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Bicalutamide Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Bicalutamide Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Bicalutamide Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Bicalutamide Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Bicalutamide Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Bicalutamide

    • Figure of Bicalutamide Picture

    • Table Global Bicalutamide Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Bicalutamide Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Capsule Consumption and Growth Rate (2017-2022)

    • Figure Global Single Drug For Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Combined Chemotherapy For Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Combined Radiation Therapy Or Castration For Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Bicalutamide Consumption by Country (2017-2022)

    • Table North America Bicalutamide Consumption by Country (2017-2022)

    • Figure United States Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Canada Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Mexico Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table Europe Bicalutamide Consumption by Country (2017-2022)

    • Figure Germany Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure UK Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Spain Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Belgium Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure France Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Italy Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Denmark Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Finland Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Norway Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Sweden Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Poland Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Russia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Turkey Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table APAC Bicalutamide Consumption by Country (2017-2022)

    • Figure China Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Japan Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure India Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure South Korea Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Thailand Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Singapore Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Philippines Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table South America Bicalutamide Consumption by Country (2017-2022)

    • Figure Brazil Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Colombia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Chile Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Argentina Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Peru Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table GCC Bicalutamide Consumption by Country (2017-2022)

    • Figure Bahrain Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Oman Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Qatar Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table Africa Bicalutamide Consumption by Country (2017-2022)

    • Figure Nigeria Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure South Africa Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Egypt Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure Algeria Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table Oceania Bicalutamide Consumption by Country (2017-2022)

    • Figure Australia Bicalutamide Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Bicalutamide Consumption and Growth Rate (2017-2022)

    • Table Zhejiang Haizheng Pharmaceutical Company Details

    • Table Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang Haizheng Pharmaceutical Bicalutamide Main Business and Markets Served

    • Table Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolio

    • Table Shanghai Fudan Fuhua Pharmaceutical Company Details

    • Table Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Main Business and Markets Served

    • Table Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolio

    • Table Apotex Corporation Company Details

    • Table Apotex Corporation Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Corporation Bicalutamide Main Business and Markets Served

    • Table Apotex Corporation Bicalutamide Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Bicalutamide Main Business and Markets Served

    • Table AstraZeneca Bicalutamide Product Portfolio

    • Table Sivem Pharmaceuticals Company Details

    • Table Sivem Pharmaceuticals Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sivem Pharmaceuticals Bicalutamide Main Business and Markets Served

    • Table Sivem Pharmaceuticals Bicalutamide Product Portfolio

    • Table CORDEN PHARMA GMBH Company Details

    • Table CORDEN PHARMA GMBH Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table CORDEN PHARMA GMBH Bicalutamide Main Business and Markets Served

    • Table CORDEN PHARMA GMBH Bicalutamide Product Portfolio

    • Table Sorres Pharma Company Details

    • Table Sorres Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorres Pharma Bicalutamide Main Business and Markets Served

    • Table Sorres Pharma Bicalutamide Product Portfolio

    • Table Zeneca GmbH Company Details

    • Table Zeneca GmbH Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zeneca GmbH Bicalutamide Main Business and Markets Served

    • Table Zeneca GmbH Bicalutamide Product Portfolio

    • Table Accel Pharma Company Details

    • Table Accel Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accel Pharma Bicalutamide Main Business and Markets Served

    • Table Accel Pharma Bicalutamide Product Portfolio

    • Table Fresenius Kabi Company Details

    • Table Fresenius Kabi Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi Bicalutamide Main Business and Markets Served

    • Table Fresenius Kabi Bicalutamide Product Portfolio

    • Table Actavis Pharma Company Details

    • Table Actavis Pharma Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Pharma Bicalutamide Main Business and Markets Served

    • Table Actavis Pharma Bicalutamide Product Portfolio

    • Table ANI Pharmaceuticals Company Details

    • Table ANI Pharmaceuticals Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table ANI Pharmaceuticals Bicalutamide Main Business and Markets Served

    • Table ANI Pharmaceuticals Bicalutamide Product Portfolio

    • Table Shanghai Zhaohui Pharmaceutical Company Details

    • Table Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Zhaohui Pharmaceutical Bicalutamide Main Business and Markets Served

    • Table Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolio

    • Table Shanxi Zhendong Pharmaceutical Company Details

    • Table Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanxi Zhendong Pharmaceutical Bicalutamide Main Business and Markets Served

    • Table Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolio

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Single Drug For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combined Chemotherapy For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combined Radiation Therapy Or Castration For Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bicalutamide Consumption Forecast by Country (2022-2028)

    • Table North America Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure United States Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure Germany Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure China Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure Brazil Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Bicalutamide Consumption Forecast by Country (2022-2028)

    • Figure Australia Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Bicalutamide Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US